Latest Remicade news
Early Use of Higher-Efficacy Therapies Recommended for Moderate-to-Severe Crohn Disease
posted November 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Risk for Herpes Zoster Elevated for Individuals With Atopic Dermatitis 
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer .jpg)
Once-Weekly Oral Islatravir-Lenacapavir Noninferior to Daily B/F/TAF in HIV Related Articles
Randomized Trial of Early Vitrectomy Feasible for Postoperative Endophthalmitis 
28 Percent of U.S. Adults With HTN Eligible for Treatment Under New Guidelines 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine 
Setmelanotide Beneficial in Acquired Hypothalamic Obesity Monthly Specialist Briefings
Stay Connected
